Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Two-Photon Microscopy

August 31, 2011 8:12 am | Product Releases | Comments

Special Optics offers objective lens solutions optimized for use in two-photon microscopy systems. These apochromatic objectives are customized with high numerical apertures and long working distances for use with various sample sizes and applications.


3M Licenses BART Technology

August 31, 2011 8:04 am | News | Comments

Lumora Ltd and 3M have signed a joint development and licensing agreement. Conclusion The agreement allows 3M to develop and sell nucleic acid test kits utilising Lumora’s BART technology.


New Device to Attack Heart of Tumors

August 31, 2011 7:55 am | News | Comments

Researchers have created and tested miniature devices that are implanted in tumors to generate oxygen, boosting the killing power of radiation and chemotherapy.


COTI-2 Inhibits Cancer Cells

August 31, 2011 7:48 am | News | Comments

Critical Outcome Technologies Inc. announced recent experiments demonstrating clear evidence of COTI-2's ability to significantly inhibit the growth of cancer cells that over express Akt/Akt2, confirming it as a promising targeted therapy candidate.


Daiichi Sankyo Submits sNDA

August 31, 2011 7:34 am | News | Comments

Daiichi Sankyo Company submitted a supplemental New Drug Application for an additional indication of Diagnogreen 25 mg intravenous injection for near-infrared fluorescence angiography during cerebrovascular surgery.


Valeant Buying Afexa for $77M

August 31, 2011 7:26 am | News | Comments

Canadian drugmaker Valeant Pharmaceuticals International Inc. said it will buy cold remedy maker Afexa Life Sciences Inc. for about $77.6 million.


Analyst Upgrades Alkermes' Shares

August 31, 2011 7:22 am | News | Comments

A Caris & Co. analyst upgraded the stock of drug developer Alkermes Inc., pointing to the company's pending acquisition of a drug technology business.


Rough Start for Benlysta

August 31, 2011 7:14 am | News | Comments

A new lupus treatment developed by Human Genome Sciences Inc. is receiving a lukewarm reception from doctors so far, with demand for the drug shaping up to be much softer than expected, according to a Citi analyst.


NIH Database to Speed Research Up for Brain Injuries

August 30, 2011 12:32 pm | News | Comments

The National Institutes of Health, in partnership with the Department of Defense, is building a central database on traumatic brain injuries.


Kuros Completes Patient Recruitment for KUR-023

August 30, 2011 12:28 pm | News | Comments

Kuros Biosurgery completed patient recruitment in a clinical trial investigating the safety and efficacy of KUR-023, its novel dural sealant product candidate.


Inspiration, Ipsen Partner on Hemophilia Launch

August 30, 2011 12:24 pm | News | Comments

Ipsen and Inspiration Biopharmaceuticals Inc. entered into a strategic partnership agreement, to create a European hemophilia commercial organization, to launch Inspiration’s hemophilia product portfolio in Europe.


Trying to Starve Breast Cancer Cells

August 30, 2011 12:20 pm | News | Comments

The most common breast cancer uses the most efficient, powerful food delivery system known in human cells and blocking that system kills it, researchers report.


Scripps Research and Stanford Scientists Find Drug Candidates

August 30, 2011 12:15 pm | News | Comments

Collaborating researchers at Stanford University and The Scripps Research Institute have identified chemical compounds that show promise as potential therapeutics for a set of medical conditions caused by the abnormal clumping together of a protein known as transthyretin (TTR).


Identified Gene Mutation May Underlie Other Cancer Types

August 30, 2011 12:11 pm | News | Comments

Scientists have found that individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer -- mesothelioma, and melanoma of the eye.


Childhood Cancers Take a Beating from Virus

August 30, 2011 12:06 pm | News | Comments

Yale University researchers are looking to fight a form of cancer primarily found in children and young adults with a virus from the same family as the rabies virus.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.